Loading…
A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry
Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk crit...
Saved in:
| Published in: | American journal of respiratory and critical care medicine 2017-01, Vol.195 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | |
| container_issue | |
| container_start_page | |
| container_title | American journal of respiratory and critical care medicine |
| container_volume | 195 |
| creator | Boucly, A Jais, X Cottin, V Savale, L Prevot, G O'Connell, C Picard, F Weatherald, J Groote, P De Jevnikar, M Bergot, E Chaouat, A Chabanne, C Bourdin, A Rottat, L Montani, D Simonneau, G Humbert, M Sitbon, O |
| description | Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk criteria achieved at the first follow-up visit: NYHA FC I or II, 6MWD > 440m, right atrial pressure (RAP) < 8 mmHg and cardiac index (CI) > 2.5 L/min/m2. |
| format | article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1926868002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1926868002</sourcerecordid><originalsourceid>FETCH-proquest_journals_19268680023</originalsourceid><addsrcrecordid>eNqNit1ugjAYQMmyJXM_7_Alux1J-VHBO6IViNoSWhK9MmR2Wocta-GCF9vzjYs9wK7OSc65cybeNJi6YTxH96OjeeCGYbx_dJ6svSLk-ZGHJs5P4kVQQUo58AzDltLNAlZllbJ34HSfk5EpJphBQlZQ5mwDCWOYsR0mHHICRbXdUZKUB8gOBS45JiynZAGltF-wrDtx1kYKC2ujb4B7o1tRK0h7eRKNVGNI2raR4gRcA7-I8RPq4wJF39y0qs0A2dAK0wllpVZQirO0nRlenIfPurHi9Y_Pztsa82XmtkZ_98J2x6vujRrT0Yv9WTSLEPKD_12_Rr9dbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1926868002</pqid></control><display><type>article</type><title>A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry</title><source>Freely Accessible Science Journals - check A-Z of ejournals</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Boucly, A ; Jais, X ; Cottin, V ; Savale, L ; Prevot, G ; O'Connell, C ; Picard, F ; Weatherald, J ; Groote, P De ; Jevnikar, M ; Bergot, E ; Chaouat, A ; Chabanne, C ; Bourdin, A ; Rottat, L ; Montani, D ; Simonneau, G ; Humbert, M ; Sitbon, O</creator><creatorcontrib>Boucly, A ; Jais, X ; Cottin, V ; Savale, L ; Prevot, G ; O'Connell, C ; Picard, F ; Weatherald, J ; Groote, P De ; Jevnikar, M ; Bergot, E ; Chaouat, A ; Chabanne, C ; Bourdin, A ; Rottat, L ; Montani, D ; Simonneau, G ; Humbert, M ; Sitbon, O</creatorcontrib><description>Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk criteria achieved at the first follow-up visit: NYHA FC I or II, 6MWD > 440m, right atrial pressure (RAP) < 8 mmHg and cardiac index (CI) > 2.5 L/min/m2.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><language>eng</language><publisher>New York: American Thoracic Society</publisher><subject>Multivariate analysis ; Pulmonary hypertension ; Risk assessment</subject><ispartof>American journal of respiratory and critical care medicine, 2017-01, Vol.195</ispartof><rights>Copyright American Thoracic Society 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Boucly, A</creatorcontrib><creatorcontrib>Jais, X</creatorcontrib><creatorcontrib>Cottin, V</creatorcontrib><creatorcontrib>Savale, L</creatorcontrib><creatorcontrib>Prevot, G</creatorcontrib><creatorcontrib>O'Connell, C</creatorcontrib><creatorcontrib>Picard, F</creatorcontrib><creatorcontrib>Weatherald, J</creatorcontrib><creatorcontrib>Groote, P De</creatorcontrib><creatorcontrib>Jevnikar, M</creatorcontrib><creatorcontrib>Bergot, E</creatorcontrib><creatorcontrib>Chaouat, A</creatorcontrib><creatorcontrib>Chabanne, C</creatorcontrib><creatorcontrib>Bourdin, A</creatorcontrib><creatorcontrib>Rottat, L</creatorcontrib><creatorcontrib>Montani, D</creatorcontrib><creatorcontrib>Simonneau, G</creatorcontrib><creatorcontrib>Humbert, M</creatorcontrib><creatorcontrib>Sitbon, O</creatorcontrib><title>A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry</title><title>American journal of respiratory and critical care medicine</title><description>Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk criteria achieved at the first follow-up visit: NYHA FC I or II, 6MWD > 440m, right atrial pressure (RAP) < 8 mmHg and cardiac index (CI) > 2.5 L/min/m2.</description><subject>Multivariate analysis</subject><subject>Pulmonary hypertension</subject><subject>Risk assessment</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNit1ugjAYQMmyJXM_7_Alux1J-VHBO6IViNoSWhK9MmR2Wocta-GCF9vzjYs9wK7OSc65cybeNJi6YTxH96OjeeCGYbx_dJ6svSLk-ZGHJs5P4kVQQUo58AzDltLNAlZllbJ34HSfk5EpJphBQlZQ5mwDCWOYsR0mHHICRbXdUZKUB8gOBS45JiynZAGltF-wrDtx1kYKC2ujb4B7o1tRK0h7eRKNVGNI2raR4gRcA7-I8RPq4wJF39y0qs0A2dAK0wllpVZQirO0nRlenIfPurHi9Y_Pztsa82XmtkZ_98J2x6vujRrT0Yv9WTSLEPKD_12_Rr9dbA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Boucly, A</creator><creator>Jais, X</creator><creator>Cottin, V</creator><creator>Savale, L</creator><creator>Prevot, G</creator><creator>O'Connell, C</creator><creator>Picard, F</creator><creator>Weatherald, J</creator><creator>Groote, P De</creator><creator>Jevnikar, M</creator><creator>Bergot, E</creator><creator>Chaouat, A</creator><creator>Chabanne, C</creator><creator>Bourdin, A</creator><creator>Rottat, L</creator><creator>Montani, D</creator><creator>Simonneau, G</creator><creator>Humbert, M</creator><creator>Sitbon, O</creator><general>American Thoracic Society</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170101</creationdate><title>A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry</title><author>Boucly, A ; Jais, X ; Cottin, V ; Savale, L ; Prevot, G ; O'Connell, C ; Picard, F ; Weatherald, J ; Groote, P De ; Jevnikar, M ; Bergot, E ; Chaouat, A ; Chabanne, C ; Bourdin, A ; Rottat, L ; Montani, D ; Simonneau, G ; Humbert, M ; Sitbon, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19268680023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Multivariate analysis</topic><topic>Pulmonary hypertension</topic><topic>Risk assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boucly, A</creatorcontrib><creatorcontrib>Jais, X</creatorcontrib><creatorcontrib>Cottin, V</creatorcontrib><creatorcontrib>Savale, L</creatorcontrib><creatorcontrib>Prevot, G</creatorcontrib><creatorcontrib>O'Connell, C</creatorcontrib><creatorcontrib>Picard, F</creatorcontrib><creatorcontrib>Weatherald, J</creatorcontrib><creatorcontrib>Groote, P De</creatorcontrib><creatorcontrib>Jevnikar, M</creatorcontrib><creatorcontrib>Bergot, E</creatorcontrib><creatorcontrib>Chaouat, A</creatorcontrib><creatorcontrib>Chabanne, C</creatorcontrib><creatorcontrib>Bourdin, A</creatorcontrib><creatorcontrib>Rottat, L</creatorcontrib><creatorcontrib>Montani, D</creatorcontrib><creatorcontrib>Simonneau, G</creatorcontrib><creatorcontrib>Humbert, M</creatorcontrib><creatorcontrib>Sitbon, O</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boucly, A</au><au>Jais, X</au><au>Cottin, V</au><au>Savale, L</au><au>Prevot, G</au><au>O'Connell, C</au><au>Picard, F</au><au>Weatherald, J</au><au>Groote, P De</au><au>Jevnikar, M</au><au>Bergot, E</au><au>Chaouat, A</au><au>Chabanne, C</au><au>Bourdin, A</au><au>Rottat, L</au><au>Montani, D</au><au>Simonneau, G</au><au>Humbert, M</au><au>Sitbon, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>195</volume><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Introduction Current European (ERS/ESC) pulmonary hypertension (PH) guidelines recommend risk assessment at the time of diagnosis and at regular follow-up in patients with pulmonary arterial hypertension (PAH). The Cox-proportional hazards model was used to determine the weight of four low-risk criteria achieved at the first follow-up visit: NYHA FC I or II, 6MWD > 440m, right atrial pressure (RAP) < 8 mmHg and cardiac index (CI) > 2.5 L/min/m2.</abstract><cop>New York</cop><pub>American Thoracic Society</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1073-449X |
| ispartof | American journal of respiratory and critical care medicine, 2017-01, Vol.195 |
| issn | 1073-449X 1535-4970 |
| language | eng |
| recordid | cdi_proquest_journals_1926868002 |
| source | Freely Accessible Science Journals - check A-Z of ejournals; Free E-Journal (出版社公開部分のみ） |
| subjects | Multivariate analysis Pulmonary hypertension Risk assessment |
| title | A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Risk Categories From European Guidelines Applied To The French Pulmonary Hypertension Registry |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A25%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A18%20U%20GOT%20THE%20LOOK:%20DRUGS,%20TOXINS,%20GENES%20AND%20RISK%20ASSESSMENT%20IN%20PULMONARY%20HYPERTENSION:%20Risk%20Categories%20From%20European%20Guidelines%20Applied%20To%20The%20French%20Pulmonary%20Hypertension%20Registry&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Boucly,%20A&rft.date=2017-01-01&rft.volume=195&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/&rft_dat=%3Cproquest%3E1926868002%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_19268680023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1926868002&rft_id=info:pmid/&rfr_iscdi=true |